Showing results (1-10 of 709) with videos related to
Sort By:
Pageof 71
Forensic Science International. Genetics|June 20, 2017
Characterisation of artefacts and drop-in events using STR-validator and single-cell analysisOskar Hansson, Peter GillLakartidningen|May 31, 2024
[Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease]Kaj Blennow, Oskar HanssonAlzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2021
Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's diseaseRik Ossenkoppele, Oskar HanssonTrends in Neurosciences|March 1, 2022
Subtypes of Alzheimer's disease: questions, controversy, and meaningJacob W Vogel, Oskar HanssonJournal of Alzheimer'S Disease : JAD|August 14, 2023
Intracellular Amyloid-β in the Normal Rat Brain and Human Subjects and Its relevance for Alzheimer's DiseaseAsgeir Kobro-Flatmoen, Thea Meier Hormann, Gunnar GourasCurrent Alzheimer Research|November 1, 2021
Cerebrospinal Fluid Biomarker Levels as Markers for Nursing Home Placement and Survival Time in Alzheimer's DiseaseCarina Wattmo, Kaj Blennow, Oskar HanssonBMC Neurology|January 11, 2020
Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's diseaseCarina Wattmo, Kaj Blennow, Oskar HanssonBMC Neurology|February 6, 2015
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's diseaseEdina Silajdžić, Maria Björkqvist, Oskar HanssonBrain : a Journal of Neurology|March 4, 2016
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomographySebastian Palmqvist, Niklas Mattsson, Oskar Hansson, et al.Pageof 71